Literature DB >> 6942634

In-hospital ventricular fibrillation and its relation to serum potassium.

J Hulting.   

Abstract

Serum potassium (S-K) has been related to the incidence of ventricular fibrillation (VF) before admission to, and during observation in a coronary care unit (CCU). The series comprises 1315 patients. Acute myocardial infarction (AMI) was diagnosed in 537 patients. VF occurred in 46 patients. Fourteen of these had their VF before admission to the CCU. The incidence of VF within 12 h after CCU admission (early VF) was significantly raised (p less than 0.01) in patients with an initial S-K less than 3.9 mmol . l-1. In this group, the incidence of early VF in all patients and in those with AMI amounted to 3.0 and 5.4%, respectively. Corresponding figures in patients with an initial S-K of 3.9 mmol . l-1 or above were 0.6 and 1.5%. Thus, a near 5-fold increase in the incidence of early VF was observed with a S-K below 3.9 mmol . l-1. Patients with VF occurring later than 12 h after admission had significantly higher S-K values than those with early VF. In AMI, the risk of primary and secondary VF seemed to be equally increased with low initial S-K values. There was a strong correlation between myocardial infarction size and the risk of VF. No relationship, however, was noted between infarction size and initial S-K.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6942634     DOI: 10.1111/j.0954-6820.1981.tb02646.x

Source DB:  PubMed          Journal:  Acta Med Scand Suppl        ISSN: 0365-463X


  24 in total

1.  Effects of hydrochlorothiazide, amiloride, and lisinopril on the metabolic response to adrenaline infusions in normal subjects.

Authors:  O Hansen; B W Johansson
Journal:  Cardiovasc Drugs Ther       Date:  1992-06       Impact factor: 3.727

Review 2.  Diuretic-induced hypokalaemia and surgery: much ado about nothing?

Authors:  L J Restrick; N Huddy; B I Hoffbrand
Journal:  Postgrad Med J       Date:  1992-05       Impact factor: 2.401

3.  The impact of serum potassium-influencing antihypertensive drugs on the risk of out-of-hospital cardiac arrest: A case-control study.

Authors:  Fawaz F Alharbi; Patrick C Souverein; Mark C H de Groot; Marieke T Blom; Anthonius de Boer; Olaf H Klungel; Hanno L Tan
Journal:  Br J Clin Pharmacol       Date:  2017-08-16       Impact factor: 4.335

4.  Serum Potassium, Mortality, and Kidney Outcomes in the Atherosclerosis Risk in Communities Study.

Authors:  Yan Chen; Alex R Chang; Mara A McAdams DeMarco; Lesley A Inker; Kunihiro Matsushita; Shoshana H Ballew; Josef Coresh; Morgan E Grams
Journal:  Mayo Clin Proc       Date:  2016-08-04       Impact factor: 7.616

5.  The effect of patient-controlled intravenous analgesia on postoperative hypokalemia in patients undergoing laparoscopic cholecystectomy.

Authors:  Won Ho Kim; Jong Hwan Lee; Justin Sangwook Ko; Tae Soo Hahm; Sangmin M Lee; Hyun Sung Cho
Journal:  J Anesth       Date:  2011-08-24       Impact factor: 2.078

6.  Serum potassium levels, cardiac arrhythmias, and mortality following non-ST-elevation myocardial infarction or unstable angina: insights from MERLIN-TIMI 36.

Authors:  Ravi B Patel; Sara Tannenbaum; Ana Viana-Tejedor; Jianping Guo; KyungAh Im; David A Morrow; Benjamin M Scirica
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2016-09-20

Review 7.  Electrolyte abnormalities and ventricular arrhythmias.

Authors:  P V Caralis; E Perez-Stable
Journal:  Drugs       Date:  1986       Impact factor: 9.546

8.  Malignant arrhythmias in acute myocardial infarction. Relationship to serum potassium and effect of selective and non-selective beta-blockade.

Authors:  B W Johansson; R Dziamski
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

9.  Ventricular arrhythmias in patients with myocardial infarction and ischaemia. The role of serum potassium.

Authors:  R J Solomon
Journal:  Drugs       Date:  1986       Impact factor: 9.546

10.  Ventricular fibrillation and initial plasma potassium in acute myocardial infarction.

Authors:  R D Thomas
Journal:  Postgrad Med J       Date:  1983-06       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.